GLP-1 Research
A PubMed-backed breakdown of whether Ozempic is safe for men with type 2 diabetes, covering cardiovascular outcomes, real…
New research reveals that GLP-1 medications like semaglutide significantly reshape the gut microbiome — and understanding this connection…
Ozempic was built for diabetes, but emerging research shows semaglutide offers significant benefits for heart disease, kidney protection,…
Ozempic can lead to muscle loss, but the research shows it's the caloric deficit — not the drug…
Emerging research is examining whether GLP-1 receptor agonists influence aortic aneurysm and dissection risk — here's what the…
Mounjaro and Zepbound are both brand names for tirzepatide, a dual GLP-1/GIP receptor agonist from Eli Lilly —…
Emerging research reveals that GLP-1 medications do far more than suppress appetite — they actively modulate immune function…
Semaglutide is a synthetic peptide — a 31-amino-acid analog of the gut hormone GLP-1 — and understanding its…
New research reveals that GLP-1 receptor agonists reduce systemic inflammation through multiple direct pathways — with implications for…
A science-backed breakdown of how GLP-1 medications work, what they actually deliver for metabolic health, and the muscle…